River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fourth quarter ...

Elevance Health (ELV) Q4 CY2024 Highlights: ・ Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) ・ Adjusted EPS: $3.84 vs analyst expectations ...

Leon Cooperman’s portfolio grew to $2.64B with shifts in top holdings, new stakes in KBR & Las Vegas Sands, and notable ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future growth. Read why ELV stock remains a Buy.

In a regulatory filing, Elevance Health (ELV) disclosed that its officers ... to be consistent with the guidance provided in its Q4 earnings release, dated January 23, including expectations ...

Elevance Health, Inc. (NYSE:ELV ... the company was able to distribute dividends worth $373 million in Q4. On January 23, it declared a 4.9% hike in its quarterly dividend to $1.71 per share.

Elevance Health continues to capitalize on its enviable position as the exclusive licensee of the Blue Cross Blue Shield brand in 14 states. We believe that the Blue Cross Blue Shield brand is the ...

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.

Artisan Select Equity Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “Elevance Health, Inc. (NYSE:ELV) took a couple of blows this quarter.

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the ...